Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3510LO2W
Performance in the last:
Follow this Portfolio
1D 0.6 %
1W -4.7 %
2W -7.7 %
1M 12.2 %
3M 10.9 %
6M 16.6 %
9M 7.4 %
1Y 16.8 %
Alpha
-3.4%
Beta
0.62
sharpe-R
0.59
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.5
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-11-22 08:47:42
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -18.3%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 10.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
ITGR Integer Holdings Corporation Equity Buy 8.88% -0.64%
The percentage of cash held in the portfolio is: 91.12%
** The description of each asset is available Here

The latest 5 Compositions change

2024-11-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 8.74% -2.48%
The percentage of cash held in the portfolio is: 91.26%
New Assets Added
None
Assets Removed
Asset Action Perf %
HUM Sell All 1.89%
Assets Rebalanced
None
2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
HUM Humana Inc. Buy 8.5% -3.72%
ITGR Integer Holdings Corporation Buy 8.79% -2.37%
The percentage of cash held in the portfolio is: 82.72%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDRX Sell All -7.2%
Assets Rebalanced
None
2024-11-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
HUM Humana Inc. Buy 8.29% -5.95%
ITGR Integer Holdings Corporation Buy 8.84% -1.63%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.22% -4.98%
The percentage of cash held in the portfolio is: 71.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
AVNS Sell All -8.39%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
AVNS Avanos Medical, Inc. Buy 8.52% -5.56%
HUM Humana Inc. Buy 8.4% -4.45%
ITGR Integer Holdings Corporation Buy 8.73% -2.62%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.16% -5.24%
The percentage of cash held in the portfolio is: 63.18%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All -17.11%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
AVNS Avanos Medical, Inc. Buy 8.57% -3.19%
HUM Humana Inc. Buy 8.46% -1.86%
ITGR Integer Holdings Corporation Buy 8.67% -1.41%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.11% -3.91%
RGEN Repligen Corporation Buy 9.65% -5.34%
The percentage of cash held in the portfolio is: 53.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATEC Sell All 11.21%
ALT Sell All -10.91%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATEC Alphatec Holdings, Inc. Buy 10.57% 16.31%
AVNS Avanos Medical, Inc. Buy 8.45% -1.47%
HUM Humana Inc. Buy 8.38% 0.32%
ITGR Integer Holdings Corporation Buy 8.57% 0.58%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.1% -0.89%
ALT Altimmune, Inc. Buy 11.41% 0.32%
RGEN Repligen Corporation Buy 9.88% 0%
The percentage of cash held in the portfolio is: 31.63%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
CARA Sell All -6.09%
INCY Sell All 8.86%
ESPR Sell All -11.51%
Assets Rebalanced
None
2024-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
INCY Incyte Corporation Buy 9.7% 8.99%
ATEC Alphatec Holdings, Inc. Buy 10.61% 18.22%
AVNS Avanos Medical, Inc. Buy 8.52% 0.61%
HUM Humana Inc. Buy 8.01% -2.93%
CARA Cara Therapeutics, Inc. Buy 8.71% -1.16%
ITGR Integer Holdings Corporation Buy 8.42% 0.1%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.92% -1.24%
ESPR Esperion Therapeutics, Inc. Buy 10.66% -3.57%
ALT Altimmune, Inc. Buy 11.23% 0%
The percentage of cash held in the portfolio is: 13.23%
New Assets Added
  • ALT
Assets Removed
Asset Action Perf %
AVXL Sell All 36.25%
NEOG Sell All 6.97%
Assets Rebalanced
None
2024-11-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 10.61% 14.37%
INCY Incyte Corporation Buy 9.57% 10.28%
ATEC Alphatec Holdings, Inc. Buy 10.81% 23.57%
AVXL Anavex Life Sciences Corp. Buy 12.09% 38.22%
AVNS Avanos Medical, Inc. Buy 8.64% 4.6%
HUM Humana Inc. Buy 7.87% -2.1%
CARA Cara Therapeutics, Inc. Buy 8.49% -1.16%
ITGR Integer Holdings Corporation Buy 8.36% 2%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.78% 0%
ESPR Esperion Therapeutics, Inc. Buy 10.78% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
  • ESPR
Assets Removed
Asset Action Perf %
HCSG Sell All 11.51%
IOVA Sell All -3.45%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 11.31% 8.4%
IOVA Iovance Biotherapeutics, Inc. Buy 10.02% -3.99%
NEOG Neogen Corporation Buy 10.57% 13.18%
INCY Incyte Corporation Buy 9.85% 12.78%
ATEC Alphatec Holdings, Inc. Buy 10.54% 19.75%
AVXL Anavex Life Sciences Corp. Buy 12.29% 39.58%
AVNS Avanos Medical, Inc. Buy 8.58% 3.19%
HUM Humana Inc. Buy 8.08% -0.14%
CARA Cara Therapeutics, Inc. Buy 8.52% -1.45%
ITGR Integer Holdings Corporation Buy 8.25% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ITGR
Assets Removed
Asset Action Perf %
IART Sell All -0.52%
Assets Rebalanced
None
2024-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 11.27% 7.31%
IOVA Iovance Biotherapeutics, Inc. Buy 11.69% 11.33%
NEOG Neogen Corporation Buy 10.35% 10.04%
INCY Incyte Corporation Buy 9.79% 11.38%
ATEC Alphatec Holdings, Inc. Buy 10.63% 19.87%
AVXL Anavex Life Sciences Corp. Buy 10.22% 15.33%
IART Integra LifeSciences Holdings Corporation Buy 8.57% 2.41%
AVNS Avanos Medical, Inc. Buy 8.64% 3.29%
HUM Humana Inc. Buy 8.13% -0.26%
CARA Cara Therapeutics, Inc. Buy 8.71% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CARA
Assets Removed
Asset Action Perf %
NVRO Sell All -1.11%
Assets Rebalanced
None
2024-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 11.32% 8.49%
IOVA Iovance Biotherapeutics, Inc. Buy 11.48% 10.06%
NEOG Neogen Corporation Buy 10.18% 8.93%
NVRO Nevro Corp. Buy 9.35% 7.04%
INCY Incyte Corporation Buy 9.56% 9.5%
ATEC Alphatec Holdings, Inc. Buy 9.95% 12.99%
AVXL Anavex Life Sciences Corp. Buy 10.36% 17.67%
IART Integra LifeSciences Holdings Corporation Buy 8.91% 7.19%
AVNS Avanos Medical, Inc. Buy 8.8% 5.92%
HUM Humana Inc. Buy 8.09% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HUM
Assets Removed
Asset Action Perf %
CDMO Sell All 5.98%
Assets Rebalanced
None
2024-11-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 8.17% 1.74%
HCSG Healthcare Services Group, Inc. Buy 11.3% 4.02%
IOVA Iovance Biotherapeutics, Inc. Buy 11.48% 5.71%
NEOG Neogen Corporation Buy 10.19% 4.74%
NVRO Nevro Corp. Buy 9.36% 2.96%
INCY Incyte Corporation Buy 9.5% 4.53%
ATEC Alphatec Holdings, Inc. Buy 10.02% 9.3%
AVXL Anavex Life Sciences Corp. Buy 10.66% 16.31%
IART Integra LifeSciences Holdings Corporation Buy 8.65% 0%
AVNS Avanos Medical, Inc. Buy 8.65% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • IART
  • AVNS
Assets Removed
Asset Action Perf %
NUTX Sell All 0.73%
PTCT Sell All 3.94%
Assets Rebalanced
None
2024-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 8.19% -10.19%
PTCT PTC Therapeutics, Inc. Buy 9.26% 1.53%
CDMO Avid Bioservices, Inc. Buy 8.26% -3.86%
HCSG Healthcare Services Group, Inc. Buy 11.64% 0.18%
IOVA Iovance Biotherapeutics, Inc. Buy 11% -5.35%
NEOG Neogen Corporation Buy 10.36% -0.42%
NVRO Nevro Corp. Buy 9.92% 2.04%
INCY Incyte Corporation Buy 9.75% 0.26%
ATEC Alphatec Holdings, Inc. Buy 9.81% 0%
AVXL Anavex Life Sciences Corp. Buy 9.81% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ATEC
  • AVXL
Assets Removed
Asset Action Perf %
VREX Sell All 8.51%
Assets Rebalanced
None
2024-10-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 9.86% 10.33%
NUTX Nutex Health Inc. Buy 8.51% -5.16%
PTCT PTC Therapeutics, Inc. Buy 9.27% 3.41%
CDMO Avid Bioservices, Inc. Buy 8.28% -2.03%
HCSG Healthcare Services Group, Inc. Buy 11.54% 0.91%
IOVA Iovance Biotherapeutics, Inc. Buy 11.44% 0.09%
NEOG Neogen Corporation Buy 10.4% 1.6%
NVRO Nevro Corp. Buy 9.57% 0%
INCY Incyte Corporation Buy 9.57% 0%
The percentage of cash held in the portfolio is: 11.57%
New Assets Added
  • NVRO
  • INCY
Assets Removed
Asset Action Perf %
ALGN Sell All -2.57%
Assets Rebalanced
None
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 9.87% 10%
NUTX Nutex Health Inc. Buy 8.02% -10.96%
PTCT PTC Therapeutics, Inc. Buy 9.74% 8.09%
CDMO Avid Bioservices, Inc. Buy 8.34% -1.74%
ALGN Align Technology, Inc. Buy 8.35% -1.68%
HCSG Healthcare Services Group, Inc. Buy 11.56% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 11.26% -1.99%
NEOG Neogen Corporation Buy 10.28% 0%
The percentage of cash held in the portfolio is: 22.57%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 9.67% 8.68%
NKTR Nektar Therapeutics Buy 8.35% -6.21%
NUTX Nutex Health Inc. Buy 8.64% -3.3%
PTCT PTC Therapeutics, Inc. Buy 9.19% 2.95%
CDMO Avid Bioservices, Inc. Buy 8.2% -2.51%
ALGN Align Technology, Inc. Buy 8.4% -0.29%
HCSG Healthcare Services Group, Inc. Buy 11.39% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 11.39% 0%
The percentage of cash held in the portfolio is: 24.77%
New Assets Added
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
ARWR Sell All 4.24%
VCEL Sell All 8.48%
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.68% 3.82%
VCEL Vericel Corporation Buy 9.69% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 14.41% 54.64%
VREX Varex Imaging Corporation Buy 10.05% 6.69%
NKTR Nektar Therapeutics Buy 8.58% -8.97%
NUTX Nutex Health Inc. Buy 9.25% -2.14%
PTCT PTC Therapeutics, Inc. Buy 9.8% 3.64%
CDMO Avid Bioservices, Inc. Buy 8.6% -3.47%
ALGN Align Technology, Inc. Buy 9.03% 1.33%
The percentage of cash held in the portfolio is: 10.91%
New Assets Added
None
Assets Removed
Asset Action Perf %
ARDX Sell All -4.47%
Assets Rebalanced
None
2024-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.03% -2.98%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.58% 2.94%
VCEL Vericel Corporation Buy 9.47% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 14.28% 53.61%
VREX Varex Imaging Corporation Buy 9.96% 5.95%
NKTR Nektar Therapeutics Buy 8.75% -6.9%
NUTX Nutex Health Inc. Buy 9.34% -0.97%
PTCT PTC Therapeutics, Inc. Buy 9.93% 5.29%
CDMO Avid Bioservices, Inc. Buy 8.76% -1.45%
ALGN Align Technology, Inc. Buy 8.89% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ALGN
Assets Removed
None
Assets Rebalanced
None
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 8.57% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.55% 2.89%
VCEL Vericel Corporation Buy 9.32% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 14.72% 58.76%
VREX Varex Imaging Corporation Buy 9.88% 5.37%
NKTR Nektar Therapeutics Buy 9.12% -2.76%
NUTX Nutex Health Inc. Buy 8.95% -4.88%
PTCT PTC Therapeutics, Inc. Buy 10.17% 8.04%
CDMO Avid Bioservices, Inc. Buy 8.87% 0%
The percentage of cash held in the portfolio is: 10.87%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.09% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10% 5.27%
VCEL Vericel Corporation Buy 9.44% -0.62%
CDXS Codexis, Inc. Buy 9.24% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 11.84% 24.74%
VREX Varex Imaging Corporation Buy 9.95% 3.64%
NKTR Nektar Therapeutics Buy 9.53% -0.69%
NUTX Nutex Health Inc. Buy 9.63% 0%
PTCT PTC Therapeutics, Inc. Buy 9.63% 0%
The percentage of cash held in the portfolio is: 11.63%
New Assets Added
  • NUTX
  • PTCT
Assets Removed
Asset Action Perf %
LXRX Sell All -3.48%
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.55% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.38% 5.84%
VCEL Vericel Corporation Buy 9.59% -2.16%
CDXS Codexis, Inc. Buy 9.51% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 9.19% -6.19%
VREX Varex Imaging Corporation Buy 10.32% 4.13%
NKTR Nektar Therapeutics Buy 9.5% -4.14%
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.61% -2.99%
The percentage of cash held in the portfolio is: 22.34%
New Assets Added
None
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.3% -3.31%
BKD Brookdale Senior Living Inc. Buy 10.47% 8.76%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.53% 9.4%
VCEL Vericel Corporation Buy 9.52% -1.02%
CDXS Codexis, Inc. Buy 9.67% 0.59%
SGMO Sangamo Therapeutics, Inc. Buy 9.13% -5.08%
VREX Varex Imaging Corporation Buy 9.93% 2.07%
NKTR Nektar Therapeutics Buy 9.46% -2.76%
LXRX Lexicon Pharmaceuticals, Inc. Buy 10.06% 3.48%
The percentage of cash held in the portfolio is: 11.93%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All 2.6%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 9.75% -0.32%
ARDX Ardelyx, Inc. Buy 9.37% -3.48%
BKD Brookdale Senior Living Inc. Buy 10.6% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.45% 7.64%
VCEL Vericel Corporation Buy 9.38% -3.37%
CDXS Codexis, Inc. Buy 9.64% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 9.4% -3.09%
VREX Varex Imaging Corporation Buy 9.81% 0%
NKTR Nektar Therapeutics Buy 9.81% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.81% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VREX
  • NKTR
  • LXRX
Assets Removed
Asset Action Perf %
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 10.09% 5.52%
ARDX Ardelyx, Inc. Buy 9.2% -3.15%
BKD Brookdale Senior Living Inc. Buy 10.48% 10.41%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.35% 8.99%
VCEL Vericel Corporation Buy 9.31% -1.95%
RDNT RadNet, Inc. Buy 9.46% -0.34%
CDXS Codexis, Inc. Buy 9.85% 3.83%
SGMO Sangamo Therapeutics, Inc. Buy 9.7% 2.27%
The percentage of cash held in the portfolio is: 21.55%
New Assets Added
None
Assets Removed
Asset Action Perf %
IRWD Sell All 5.63%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 10.07% 3.05%
ORGO Organogenesis Holdings Inc. Buy 10.16% 3.9%
ARDX Ardelyx, Inc. Buy 9.59% -1.16%
BKD Brookdale Senior Living Inc. Buy 9.73% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.96% 2.69%
VCEL Vericel Corporation Buy 9.67% -0.33%
RDNT RadNet, Inc. Buy 9.72% 0.2%
CDXS Codexis, Inc. Buy 9.7% 0%
SGMO Sangamo Therapeutics, Inc. Buy 9.7% 0%
The percentage of cash held in the portfolio is: 11.7%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.93% 0.7%
ORGO Organogenesis Holdings Inc. Buy 9.89% 0.32%
ARDX Ardelyx, Inc. Buy 9.7% -0.83%
BKD Brookdale Senior Living Inc. Buy 9.78% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.78% 0%
VCEL Vericel Corporation Buy 9.78% 0%
RDNT RadNet, Inc. Buy 9.78% 0%
The percentage of cash held in the portfolio is: 31.35%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.86% 0%
ORGO Organogenesis Holdings Inc. Buy 9.83% -0.32%
ARDX Ardelyx, Inc. Buy 9.79% 0%
The percentage of cash held in the portfolio is: 70.52%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.77% -1.17%
ORGO Organogenesis Holdings Inc. Buy 9.7% -1.95%
The percentage of cash held in the portfolio is: 80.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.88% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 9.79% 0%
ORGO Organogenesis Holdings Inc. Buy 9.79% 0%
The percentage of cash held in the portfolio is: 70.54%
New Assets Added
  • BCRX
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 90.2%
New Assets Added
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-23 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All 2.48%
Assets Rebalanced
None
2024-09-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
MYGN Myriad Genetics, Inc. Buy 9.58% 4.89%
The percentage of cash held in the portfolio is: 90.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVCR Sell All -1.16%
Assets Rebalanced
None
2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 9.1% -0.17%
MYGN Myriad Genetics, Inc. Buy 9.67% 6.04%
The percentage of cash held in the portfolio is: 81.23%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -2.73%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
ESPR Esperion Therapeutics, Inc. Buy 8.72% -3.83%
NVCR NovoCure Limited Buy 9.1% -0.5%
MYGN Myriad Genetics, Inc. Buy 9.46% 3.45%
The percentage of cash held in the portfolio is: 72.71%
New Assets Added
None
Assets Removed
Asset Action Perf %
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
TVTX Travere Therapeutics, Inc. Buy 11.92% 27.5%
ESPR Esperion Therapeutics, Inc. Buy 8.89% -4.92%
NVCR NovoCure Limited Buy 9% -4.54%
MYGN Myriad Genetics, Inc. Buy 9.18% -2.56%
The percentage of cash held in the portfolio is: 61.02%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All 11.4%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 10.99% 7.2%
TVTX Travere Therapeutics, Inc. Buy 12.53% 33.96%
ESPR Esperion Therapeutics, Inc. Buy 8.69% -7.1%
NVCR NovoCure Limited Buy 8.68% -7.98%
MYGN Myriad Genetics, Inc. Buy 9.49% 0.63%
The percentage of cash held in the portfolio is: 49.62%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
AADI Sell All 3.43%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 10.88% 4.57%
PODD Insulet Corporation Buy 10.97% 5.05%
TVTX Travere Therapeutics, Inc. Buy 10.89% 14.37%
ESPR Esperion Therapeutics, Inc. Buy 8.58% -9.84%
ALDX Aldeyra Therapeutics, Inc. Buy 9.29% -3.01%
NVCR NovoCure Limited Buy 8.98% -6.48%
MYGN Myriad Genetics, Inc. Buy 9.6% 0%
The percentage of cash held in the portfolio is: 30.81%
New Assets Added
  • MYGN
Assets Removed
None
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 10.69% 2.86%
PODD Insulet Corporation Buy 11.03% 5.72%
TVTX Travere Therapeutics, Inc. Buy 9.84% 3.44%
ESPR Esperion Therapeutics, Inc. Buy 8.94% -6.01%
ALDX Aldeyra Therapeutics, Inc. Buy 9.56% 0%
NVCR NovoCure Limited Buy 9.59% 0%
The percentage of cash held in the portfolio is: 40.36%
New Assets Added
  • NVCR
Assets Removed
Asset Action Perf %
CARA Sell All -6.41%
AGEN Sell All -8.59%
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 9.75% -6.12%
AGEN Agenus Inc. Buy 9.21% -11.33%
AADI Aadi Bioscience, Inc. Buy 10.67% 2.86%
PODD Insulet Corporation Buy 10.82% 3.96%
TVTX Travere Therapeutics, Inc. Buy 9.93% 4.69%
ESPR Esperion Therapeutics, Inc. Buy 9.44% -0.55%
ALDX Aldeyra Therapeutics, Inc. Buy 9.54% 0%
The percentage of cash held in the portfolio is: 30.63%
New Assets Added
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
APLS Sell All -5.21%
ORGO Sell All -4.59%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.08% -2.65%
ORGO Organogenesis Holdings Inc. Buy 9.99% -3.53%
CARA Cara Therapeutics, Inc. Buy 10% -3.5%
AGEN Agenus Inc. Buy 9.38% -9.51%
CERS Cerus Corporation Buy 9.52% -7.98%
AADI Aadi Bioscience, Inc. Buy 10.29% -0.57%
PODD Insulet Corporation Buy 10.5% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.3% -10.38%
TVTX Travere Therapeutics, Inc. Buy 9.47% 0%
ESPR Esperion Therapeutics, Inc. Buy 9.47% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TVTX
  • ESPR
Assets Removed
Asset Action Perf %
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.64% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 9.57% -4.2%
ORGO Organogenesis Holdings Inc. Buy 10.34% 3.53%
CARA Cara Therapeutics, Inc. Buy 10.37% 3.79%
AGEN Agenus Inc. Buy 9.33% -6.58%
CERS Cerus Corporation Buy 9.39% -5.88%
AADI Aadi Bioscience, Inc. Buy 9.58% -4%
NEOG Neogen Corporation Buy 9.77% -2.15%
PODD Insulet Corporation Buy 10.01% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.01% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.55% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 9.72% -0.64%
ORGO Organogenesis Holdings Inc. Buy 10.16% 3.89%
CARA Cara Therapeutics, Inc. Buy 10.24% 4.66%
AGEN Agenus Inc. Buy 10.07% 2.93%
CERS Cerus Corporation Buy 9.53% -2.52%
AADI Aadi Bioscience, Inc. Buy 9.38% -4%
NEOG Neogen Corporation Buy 9.78% 0%
The percentage of cash held in the portfolio is: 21.57%
New Assets Added
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.51% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 9.6% -0.05%
ORGO Organogenesis Holdings Inc. Buy 10.28% 7.07%
CARA Cara Therapeutics, Inc. Buy 10.36% 7.87%
AGEN Agenus Inc. Buy 10.3% 7.31%
CERS Cerus Corporation Buy 9.59% 0%
AADI Aadi Bioscience, Inc. Buy 9.59% 0%
The percentage of cash held in the portfolio is: 30.77%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.4% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 9.72% -1.79%
ORGO Organogenesis Holdings Inc. Buy 9.61% -2.83%
CARA Cara Therapeutics, Inc. Buy 9.9% 0%
AGEN Agenus Inc. Buy 9.9% 0%
The percentage of cash held in the portfolio is: 51.48%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.8% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 9.8% 0%
ORGO Organogenesis Holdings Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 70.6%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-12 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All -4.91%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 9.14% -7.66%
The percentage of cash held in the portfolio is: 90.86%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 1.39%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 9.6% -1.96%
RMD ResMed Inc. Buy 9.62% 7.5%
The percentage of cash held in the portfolio is: 80.78%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All -11.82%
SAVA Sell All 95.11%
SAGE Sell All -12.65%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 9.92% -1.57%
HQY HealthEquity, Inc. Buy 9.7% -3.84%
SAVA Cassava Sciences, Inc. Buy 15.87% 57.44%
SAGE Sage Therapeutics, Inc. Buy 8.95% -11.19%
HCSG Healthcare Services Group, Inc. Buy 9.21% -3.72%
RMD ResMed Inc. Buy 9.5% 3.13%
The percentage of cash held in the portfolio is: 36.84%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Sell All -12.39%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 8.07% -4.31%
CYH Community Health Systems, Inc. Buy 10.25% 3.34%
HQY HealthEquity, Inc. Buy 9.61% -3.09%
SAVA Cassava Sciences, Inc. Buy 14.77% 48.93%
SAGE Sage Therapeutics, Inc. Buy 9.88% -0.36%
HCSG Healthcare Services Group, Inc. Buy 9.3% -1.12%
RMD ResMed Inc. Buy 9.29% 2.5%
The percentage of cash held in the portfolio is: 28.84%
New Assets Added
None
Assets Removed
Asset Action Perf %
RCM Sell All -1.15%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.17% -1%
FATE Fate Therapeutics, Inc. Buy 8.08% -7.9%
CYH Community Health Systems, Inc. Buy 10.46% 1.38%
HQY HealthEquity, Inc. Buy 9.99% -3.16%
SAVA Cassava Sciences, Inc. Buy 12.15% 17.76%
SAGE Sage Therapeutics, Inc. Buy 10.14% -1.73%
HCSG Healthcare Services Group, Inc. Buy 9.74% -0.43%
RMD ResMed Inc. Buy 9.43% 0%
The percentage of cash held in the portfolio is: 20.86%
New Assets Added
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 8.84% -2.61%
FATE Fate Therapeutics, Inc. Buy 8.35% -2.87%
CLDX Celldex Therapeutics, Inc. Buy 9.68% -4.26%
SMTI Sanara MedTech Inc. Buy 9.56% -5.45%
CYH Community Health Systems, Inc. Buy 10.29% 1.77%
HQY HealthEquity, Inc. Buy 9.94% -1.69%
SAVA Cassava Sciences, Inc. Buy 12.21% 20.78%
SAGE Sage Therapeutics, Inc. Buy 9.95% -1.64%
HCSG Healthcare Services Group, Inc. Buy 9.59% 0%
The percentage of cash held in the portfolio is: 11.59%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
BKD Sell All 4.37%
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 10.8% 5.69%
RCM R1 RCM Inc. Buy 9.06% -0.19%
FATE Fate Therapeutics, Inc. Buy 8.4% -2.33%
PTGX Protagonist Therapeutics, Inc. Buy 8.86% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 10.28% 1.6%
SMTI Sanara MedTech Inc. Buy 10.12% 0%
CYH Community Health Systems, Inc. Buy 10.12% 0%
HQY HealthEquity, Inc. Buy 10.12% 0%
SAVA Cassava Sciences, Inc. Buy 10.12% 0%
SAGE Sage Therapeutics, Inc. Buy 10.12% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SMTI
  • CYH
  • HQY
  • SAVA
  • SAGE
Assets Removed
None
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 10.59% 3.44%
RCM R1 RCM Inc. Buy 9.03% -0.84%
FATE Fate Therapeutics, Inc. Buy 8.36% -3.05%
PTGX Protagonist Therapeutics, Inc. Buy 9.16% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 10.14% 0%
The percentage of cash held in the portfolio is: 52.72%
New Assets Added
  • CLDX
Assets Removed
Asset Action Perf %
ANGO Sell All 22.51%
SGRY Sell All 20.35%
AVNS Sell All 8.22%
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 11.41% 19.58%
SGRY Surgery Partners, Inc. Buy 11.08% 16.16%
AVNS Avanos Medical, Inc. Buy 10.18% 6.7%
BKD Brookdale Senior Living Inc. Buy 10.72% 3.7%
RCM R1 RCM Inc. Buy 9.27% 0.92%
FATE Fate Therapeutics, Inc. Buy 8.09% -7%
PTGX Protagonist Therapeutics, Inc. Buy 9.31% 0%
The percentage of cash held in the portfolio is: 29.94%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
PDSB Sell All 6.96%
OPK Sell All 7.58%
Assets Rebalanced
None
2024-07-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.89% 20.17%
OPK OPKO Health, Inc. Buy 9.89% 9.09%
ANGO AngioDynamics, Inc. Buy 11.42% 22.02%
SGRY Surgery Partners, Inc. Buy 10.38% 10.92%
AVNS Avanos Medical, Inc. Buy 10.03% 7.18%
BKD Brookdale Senior Living Inc. Buy 10.48% 3.31%
RCM R1 RCM Inc. Buy 9.29% 3.07%
FATE Fate Therapeutics, Inc. Buy 8.54% 0%
The percentage of cash held in the portfolio is: 19.08%
New Assets Added
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.11% 9.94%
OPK OPKO Health, Inc. Buy 10.38% 12.88%
ANGO AngioDynamics, Inc. Buy 11.12% 17.13%
SGRY Surgery Partners, Inc. Buy 10.79% 13.7%
AVNS Avanos Medical, Inc. Buy 9.86% 3.82%
BKD Brookdale Senior Living Inc. Buy 10.41% 1.19%
RCM R1 RCM Inc. Buy 9.32% 2%
The percentage of cash held in the portfolio is: 28.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
TDOC Sell All -2.99%
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.05% 9.66%
ALT Altimmune, Inc. Buy 8.02% -12.43%
OPK OPKO Health, Inc. Buy 10.55% 15.15%
ANGO AngioDynamics, Inc. Buy 10.73% 13.38%
TDOC Teladoc Health, Inc. Buy 9.4% -0.64%
SGRY Surgery Partners, Inc. Buy 10.78% 13.89%
AVNS Avanos Medical, Inc. Buy 10.03% 5.95%
BKD Brookdale Senior Living Inc. Buy 10.42% 1.59%
RCM R1 RCM Inc. Buy 8.98% -1.46%
The percentage of cash held in the portfolio is: 11.04%
New Assets Added
None
Assets Removed
Asset Action Perf %
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.13% 13.92%
ALT Altimmune, Inc. Buy 8.91% 0.13%
OPK OPKO Health, Inc. Buy 9.57% 7.58%
WST West Pharmaceutical Services, Inc. Buy 9.01% -1.88%
ANGO AngioDynamics, Inc. Buy 11.09% 20.72%
TDOC Teladoc Health, Inc. Buy 9.83% 7.04%
SGRY Surgery Partners, Inc. Buy 10.62% 15.66%
AVNS Avanos Medical, Inc. Buy 9.82% 6.89%
BKD Brookdale Senior Living Inc. Buy 10.17% 2.25%
RCM R1 RCM Inc. Buy 8.84% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 11.1% 20.03%
BHVN Biohaven Ltd. Buy 9.83% 6.27%
ALT Altimmune, Inc. Buy 9.77% 5.61%
OPK OPKO Health, Inc. Buy 10.02% 8.33%
WST West Pharmaceutical Services, Inc. Buy 9.17% -3.96%
ANGO AngioDynamics, Inc. Buy 9.24% -3.26%
TDOC Teladoc Health, Inc. Buy 9.44% -1.17%
SGRY Surgery Partners, Inc. Buy 9.62% 0.74%
AVNS Avanos Medical, Inc. Buy 9.44% -1.18%
BKD Brookdale Senior Living Inc. Buy 10.35% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BKD
Assets Removed
Asset Action Perf %
VRDN Sell All 11.2%
Assets Rebalanced
None
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 9.36% -1.97%
PDSB PDS Biotechnology Corporation Buy 10.42% 10.23%
BHVN Biohaven Ltd. Buy 9.91% 4.89%
ALT Altimmune, Inc. Buy 9.7% 2.67%
OPK OPKO Health, Inc. Buy 9.81% 3.79%
WST West Pharmaceutical Services, Inc. Buy 9.76% 0%
ANGO AngioDynamics, Inc. Buy 9.76% 0%
TDOC Teladoc Health, Inc. Buy 9.76% 0%
SGRY Surgery Partners, Inc. Buy 9.76% 0%
AVNS Avanos Medical, Inc. Buy 9.76% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • WST
  • ANGO
  • TDOC
  • SGRY
  • AVNS
Assets Removed
Asset Action Perf %
CYH Sell All 15.94%
Assets Rebalanced
None
2024-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 10.34% 4.37%
VRDN Viridian Therapeutics, Inc. Buy 9.2% -7.12%
PDSB PDS Biotechnology Corporation Buy 9.81% 0%
BHVN Biohaven Ltd. Buy 9.81% 0%
ALT Altimmune, Inc. Buy 9.81% 0%
OPK OPKO Health, Inc. Buy 9.81% 0%
The percentage of cash held in the portfolio is: 41.23%
New Assets Added
  • PDSB
  • BHVN
  • ALT
  • OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 10.28% 3.75%
VRDN Viridian Therapeutics, Inc. Buy 9.26% -6.59%
The percentage of cash held in the portfolio is: 80.47%
New Assets Added
None
Assets Removed
Asset Action Perf %
RARE Sell All 6.02%
NVRO Sell All -11.61%
Assets Rebalanced
None
2024-07-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
RARE Ultragenyx Pharmaceutical Inc. Buy 10.53% 4.12%
CYH Community Health Systems, Inc. Buy 9.99% 1.25%
NVRO Nevro Corp. Buy 9.59% -2.79%
VRDN Viridian Therapeutics, Inc. Buy 9.2% -6.81%
The percentage of cash held in the portfolio is: 60.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACAD Sell All 2.77%
EGRX Sell All 34.15%
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.09% -1.83%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.62% 22.77%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.37% 0.9%
CYH Community Health Systems, Inc. Buy 10.55% 5.31%
NVRO Nevro Corp. Buy 9.76% -2.67%
VRDN Viridian Therapeutics, Inc. Buy 9.3% -7.27%
The percentage of cash held in the portfolio is: 37.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All 1.87%
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.23% -0.25%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.98% 16.74%
STAA STAAR Surgical Company Buy 10.8% 5.2%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.55% 2.79%
CYH Community Health Systems, Inc. Buy 10.72% 7.19%
NVRO Nevro Corp. Buy 9.71% -3.02%
VRDN Viridian Therapeutics, Inc. Buy 9.21% -7.95%
The percentage of cash held in the portfolio is: 26.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All -19.65%
MNKD Sell All -7.37%
ARDX Sell All -28.74%
Assets Rebalanced
None
2024-07-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.71% 1.01%
MNKD MannKind Corporation Buy 9.01% -6.26%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.86% 23.44%
STAA STAAR Surgical Company Buy 10.77% 12.05%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.92% 3.19%
CYH Community Health Systems, Inc. Buy 9.72% 3.75%
ARDX Ardelyx, Inc. Buy 9.56% 2.16%
CHRS Coherus BioSciences, Inc. Buy 8.71% -6.94%
NVRO Nevro Corp. Buy 9.37% 0%
VRDN Viridian Therapeutics, Inc. Buy 9.37% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVRO
  • VRDN
Assets Removed
None
Assets Rebalanced
None
2024-07-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.72% 2.33%
MNKD MannKind Corporation Buy 9.14% -3.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.88% 25%
STAA STAAR Surgical Company Buy 10.69% 12.5%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.8% 3.14%
CYH Community Health Systems, Inc. Buy 9.73% 5%
ARDX Ardelyx, Inc. Buy 9.26% 0%
CHRS Coherus BioSciences, Inc. Buy 9.26% 0%
The percentage of cash held in the portfolio is: 20.52%
New Assets Added
  • ARDX
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.96% 3.09%
MNKD MannKind Corporation Buy 9.41% -2.58%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.82% 12.05%
STAA STAAR Surgical Company Buy 10.68% 10.52%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.04% 3.94%
CYH Community Health Systems, Inc. Buy 9.42% 0%
The percentage of cash held in the portfolio is: 39.67%
New Assets Added
  • CYH
Assets Removed
None
Assets Rebalanced
None
2024-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.56% -2.39%
MNKD MannKind Corporation Buy 9.37% -4.42%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.76% 9.82%
STAA STAAR Surgical Company Buy 10.54% 7.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.97% 1.71%
The percentage of cash held in the portfolio is: 49.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
FGEN Sell All -12.08%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.69% -1.76%
MNKD MannKind Corporation Buy 9.51% -3.5%
FGEN FibroGen, Inc. Buy 9.61% -2.5%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.01% 1.56%
STAA STAAR Surgical Company Buy 9.86% 0%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.86% 0%
The percentage of cash held in the portfolio is: 41.45%
New Assets Added
  • STAA
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.8% 0%
MNKD MannKind Corporation Buy 9.8% 0%
FGEN FibroGen, Inc. Buy 9.8% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 60.8%
New Assets Added
  • ACAD
  • MNKD
  • FGEN
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-05-30 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Sell All -12.31%
RCM Sell All 3.04%
BCRX Sell All -3.3%
Assets Rebalanced
None
2024-05-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 10.85% 2%
BCRX BioCryst Pharmaceuticals, Inc. Buy 10.35% -2.67%
SGMO Sangamo Therapeutics, Inc. Buy 10.72% -4.62%
The percentage of cash held in the portfolio is: 68.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
BLFS Sell All -1.34%
Assets Rebalanced
None
2024-05-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLFS BioLife Solutions, Inc. Buy 9.55% -3.17%
RCM R1 RCM Inc. Buy 10.71% -0.16%
BCRX BioCryst Pharmaceuticals, Inc. Buy 10.34% -3.62%
SGMO Sangamo Therapeutics, Inc. Buy 10.47% -7.69%
The percentage of cash held in the portfolio is: 58.94%
New Assets Added
None
Assets Removed
Asset Action Perf %
AVXL Sell All NA
EDIT Sell All NA
PACB Sell All NA
Assets Rebalanced
None
2024-05-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
AVXL Anavex Life Sciences Corp. Buy 10.27% 4.51%
EDIT Editas Medicine, Inc. Buy 10.04% 2.1%
PACB Pacific Biosciences of California, Inc. Buy 9.88% 0.52%
BLFS BioLife Solutions, Inc. Buy 9.16% -5.97%
RCM R1 RCM Inc. Buy 10.28% -2.92%
BCRX BioCryst Pharmaceuticals, Inc. Buy 10.54% -0.47%
SGMO Sangamo Therapeutics, Inc. Buy 10.68% -4.62%
The percentage of cash held in the portfolio is: 29.15%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -7.38%
Assets Rebalanced
None
2024-05-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCYT Veracyte, Inc. Buy 9.24% -3.91%
AVXL Anavex Life Sciences Corp. Buy 10.84% 12.78%
EDIT Editas Medicine, Inc. Buy 10.13% 5.43%
PACB Pacific Biosciences of California, Inc. Buy 9.21% -4.15%
BLFS BioLife Solutions, Inc. Buy 9.29% -2.45%
RCM R1 RCM Inc. Buy 10.07% -2.72%
BCRX BioCryst Pharmaceuticals, Inc. Buy 10.84% 4.72%
SGMO Sangamo Therapeutics, Inc. Buy 10.78% -1.54%
The percentage of cash held in the portfolio is: 19.59%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All -2.32%
Assets Rebalanced
None
2024-05-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCYT Veracyte, Inc. Buy 9.51% -3.2%
AVXL Anavex Life Sciences Corp. Buy 10.72% 9.02%
EDIT Editas Medicine, Inc. Buy 9.48% -3.5%
PACB Pacific Biosciences of California, Inc. Buy 9.32% -5.18%
BLFS BioLife Solutions, Inc. Buy 9.41% -3.34%
RCM R1 RCM Inc. Buy 10.4% -1.76%
BCRX BioCryst Pharmaceuticals, Inc. Buy 10.69% 0.94%
PODD Insulet Corporation Buy 8.86% -1.4%
SGMO Sangamo Therapeutics, Inc. Buy 10.34% -7.69%
The percentage of cash held in the portfolio is: 11.27%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALT Sell All -13.19%
Assets Rebalanced
None
2024-05-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCYT Veracyte, Inc. Buy 9.65% 1.69%
AVXL Anavex Life Sciences Corp. Buy 10.82% 14.04%
EDIT Editas Medicine, Inc. Buy 9.34% -1.58%
PACB Pacific Biosciences of California, Inc. Buy 9.93% 4.66%
BLFS BioLife Solutions, Inc. Buy 9.2% -2.1%
RCM R1 RCM Inc. Buy 10.17% -0.56%
BCRX BioCryst Pharmaceuticals, Inc. Buy 10.09% -1.26%
ALT Altimmune, Inc. Buy 9.23% -9.7%
PODD Insulet Corporation Buy 8.76% 1.02%
SGMO Sangamo Therapeutics, Inc. Buy 10.81% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SGMO
Assets Removed
Asset Action Perf %
OMCL Sell All 1.03%
Assets Rebalanced
None
2024-05-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 10.86% 5.08%
VCYT Veracyte, Inc. Buy 9.58% 4%
AVXL Anavex Life Sciences Corp. Buy 10.39% 12.78%
EDIT Editas Medicine, Inc. Buy 9.51% 3.15%
PACB Pacific Biosciences of California, Inc. Buy 10.46% 13.47%
BLFS BioLife Solutions, Inc. Buy 8.94% -2.05%
RCM R1 RCM Inc. Buy 9.78% -1.52%
BCRX BioCryst Pharmaceuticals, Inc. Buy 10.1% 1.73%
ALT Altimmune, Inc. Buy 9.96% 0.34%
PODD Insulet Corporation Buy 8.42% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • PODD
Assets Removed
Asset Action Perf %
MD Sell All -8.68%
Assets Rebalanced
None
2024-05-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 10.22% -0.86%
MD Pediatrix Medical Group, Inc. Buy 8.84% -3.87%
VCYT Veracyte, Inc. Buy 9.62% 4.67%
AVXL Anavex Life Sciences Corp. Buy 10.35% 12.53%
EDIT Editas Medicine, Inc. Buy 9.66% 5.08%
PACB Pacific Biosciences of California, Inc. Buy 10.24% 11.4%
BLFS BioLife Solutions, Inc. Buy 9.34% 2.5%
RCM R1 RCM Inc. Buy 9.91% 0%
BCRX BioCryst Pharmaceuticals, Inc. Buy 9.91% 0%
ALT Altimmune, Inc. Buy 9.91% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
  • BCRX
  • ALT
Assets Removed
Asset Action Perf %
INGN Sell All 25.39%
ACRS Sell All -6.35%
SGMO Sell All 7.41%
Assets Rebalanced
None
2024-05-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 11.6% 26.52%
ACRS Aclaris Therapeutics, Inc. Buy 8.58% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 9.67% 5.56%
OMCL Omnicell, Inc. Buy 10.43% 0.5%
MD Pediatrix Medical Group, Inc. Buy 9.2% -0.59%
VCYT Veracyte, Inc. Buy 9.47% 2.31%
AVXL Anavex Life Sciences Corp. Buy 9.99% 8.02%
EDIT Editas Medicine, Inc. Buy 9.2% -0.53%
PACB Pacific Biosciences of California, Inc. Buy 10.69% 15.54%
BLFS BioLife Solutions, Inc. Buy 9.17% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BLFS
Assets Removed
Asset Action Perf %
SENS Sell All 0.62%
Assets Rebalanced
None
2024-05-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
SENS Senseonics Holdings, Inc. Buy 8.67% -8.83%
INGN Inogen, Inc. Buy 11.87% 25.04%
ACRS Aclaris Therapeutics, Inc. Buy 8.89% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 9.67% 1.85%
OMCL Omnicell, Inc. Buy 10.99% 2.22%
MD Pediatrix Medical Group, Inc. Buy 9.58% 0%
VCYT Veracyte, Inc. Buy 9.58% 0%
AVXL Anavex Life Sciences Corp. Buy 9.58% 0%
EDIT Editas Medicine, Inc. Buy 9.58% 0%
PACB Pacific Biosciences of California, Inc. Buy 9.58% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
  • VCYT
  • AVXL
  • EDIT
  • PACB
Assets Removed
Asset Action Perf %
IBRX Sell All -4%
CARA Sell All -0.79%
Assets Rebalanced
None
2024-05-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
IBRX ImmunityBio, Inc. Buy 8.68% -9.68%
CARA Cara Therapeutics, Inc. Buy 9.11% -5.29%
SENS Senseonics Holdings, Inc. Buy 9.2% -4.31%
INGN Inogen, Inc. Buy 11.53% 20%
ACRS Aclaris Therapeutics, Inc. Buy 8.92% -7.14%
SGMO Sangamo Therapeutics, Inc. Buy 9.96% 3.7%
OMCL Omnicell, Inc. Buy 10.87% -0.03%
The percentage of cash held in the portfolio is: 31.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
PTCT Sell All 12.88%
IOVA Sell All -12.24%
Assets Rebalanced
None
2024-05-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.21% 8.68%
IBRX ImmunityBio, Inc. Buy 8.42% -10.34%
CARA Cara Therapeutics, Inc. Buy 9.44% 0.53%
SENS Senseonics Holdings, Inc. Buy 9.28% -1.23%
INGN Inogen, Inc. Buy 11.57% 23.26%
ACRS Aclaris Therapeutics, Inc. Buy 9.12% -2.78%
IOVA Iovance Biotherapeutics, Inc. Buy 10.1% 7.6%
SGMO Sangamo Therapeutics, Inc. Buy 9.04% -3.7%
OMCL Omnicell, Inc. Buy 10.66% 0.4%
The percentage of cash held in the portfolio is: 12.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Sell All 7.67%
Assets Rebalanced
None
2024-05-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.61% 15.54%
IBRX ImmunityBio, Inc. Buy 9.35% 1.78%
CDMO Avid Bioservices, Inc. Buy 10.02% 9.13%
CARA Cara Therapeutics, Inc. Buy 9.45% 2.94%
SENS Senseonics Holdings, Inc. Buy 9.53% 3.68%
INGN Inogen, Inc. Buy 9.3% 1.42%
ACRS Aclaris Therapeutics, Inc. Buy 9.9% 7.94%
IOVA Iovance Biotherapeutics, Inc. Buy 10% 9.04%
SGMO Sangamo Therapeutics, Inc. Buy 9.44% 2.93%
OMCL Omnicell, Inc. Buy 10.38% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • OMCL
Assets Removed
Asset Action Perf %
SMMT Sell All 13.73%
Assets Rebalanced
None
2024-05-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.35% 19.57%
SMMT Summit Therapeutics Inc. Buy 11.56% 21.76%
IBRX ImmunityBio, Inc. Buy 9.01% -5.01%
CDMO Avid Bioservices, Inc. Buy 9.63% 1.46%
CARA Cara Therapeutics, Inc. Buy 9.53% 0.4%
SENS Senseonics Holdings, Inc. Buy 9.02% -4.93%
INGN Inogen, Inc. Buy 9.48% 0%
ACRS Aclaris Therapeutics, Inc. Buy 9.48% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 9.48% 0%
SGMO Sangamo Therapeutics, Inc. Buy 9.48% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • INGN
  • ACRS
  • IOVA
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-05-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.99% 12.53%
SMMT Summit Therapeutics Inc. Buy 9.94% 1.81%
IBRX ImmunityBio, Inc. Buy 8.68% -11.12%
CDMO Avid Bioservices, Inc. Buy 9.85% 0.93%
CARA Cara Therapeutics, Inc. Buy 9.71% -0.53%
SENS Senseonics Holdings, Inc. Buy 9.77% 0%
The percentage of cash held in the portfolio is: 41.06%
New Assets Added
  • SENS
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.89% 12.5%
SMMT Summit Therapeutics Inc. Buy 9.73% 0.52%
IBRX ImmunityBio, Inc. Buy 9.67% 0%
CDMO Avid Bioservices, Inc. Buy 9.67% 0%
CARA Cara Therapeutics, Inc. Buy 9.67% 0%
The percentage of cash held in the portfolio is: 50.37%
New Assets Added
  • IBRX
  • CDMO
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 9.8% 0%
SMMT Summit Therapeutics Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • PTCT
  • SMMT
Assets Removed
None
Assets Rebalanced
None
2024-04-16 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All -6.11%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings